GLP-1 weight-loss drugs face a quality-of-life reckoning

For some patients, nausea and other gastrointestinal side effects are turning celebrated weight-loss treatments into an unsustainable daily trade-off. The surge in demand for GLP-1 medicines has transformed the obesity treatment market, with drugs such as Ozempic, Wegovy, Mounjaro and…















